Arch Biopartners, Inc. (ARCH.V)
0.80
+0.01
(+1.27%)
CAD |
TSXV |
Mar 05, 15:59
Arch Biopartners Cash from Investing (TTM) : 0.00 for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Biocure Technology, Inc. | 0.00 |
| Resverlogix Corp. | -0.7665M |
| Microbix Biosystems, Inc. | -0.7646M |
| Theratechnologies, Inc. | -8.514M |
| Helix BioPharma Corp. | 0.009M |